Enhertu 100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung - Swissmedic Key 67967001 Registration Holder Daiichi Sankyo (Schweiz) AG Name Enhertu 100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung Date of registration 29.11.2021 Introduction of Sequence 29.11.2021 ATC-Classification (L01FD04) Revision date WHO WHO-DDD Valid until 30.06.2027 Index Therapeuticus (BSV) 07.16.10. Show package size Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 1551.85 Limitation Yes Limitation text
Deductible 10 % Consumer price 1704.15 Feedback FB GTIN 7680679670013 Medication Code Biotechnologika Pharmacode Disponibility
Composition Praeparatio cryodesiccata: trastuzumabum deruxtecanum 100 mg, saccharum, histidinum, histidini hydrochloridum monohydricum, polysorbatum 80, pro vitro. Packungsbestandteile Label Praeparatio cryodesiccata:
Galenic Form Excipiens BAG: Active Agent Dose 100 mg
Inactive agents Histidin Hydrochloride Monohydrate Histidine Polysorbatum 80 Saccharum
Source Data was imported : 06.06.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
